Compounds > ursodeoxycholic acid
Page last updated: 2024-08-23

ursodeoxycholic acid and Adverse Drug Event

ursodeoxycholic acid has been researched along with Adverse Drug Event in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Aithal, GP; Alvarez-Alvarez, I; Andrade, RJ; Arikan, C; Atallah, E; Lucena, MI; Medina-Caliz, I; Niu, H1
Brackett, LM; Reddy, CA; Schneider, BJ; Tai, AW1
Malone, M1
Kawasaki, H; Murawaki, Y1

Reviews

3 review(s) available for ursodeoxycholic acid and Adverse Drug Event

ArticleYear
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
    Drug safety, 2022, Volume: 45, Issue:11

    Topics: Acetaminophen; Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Adult; Carnitine; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glycyrrhizic Acid; Humans; Infant, Newborn; Liver; Liver Failure, Acute; Retrospective Studies; S-Adenosylmethionine; Ursodeoxycholic Acid

2022
Medications associated with weight gain.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:12

    Topics: Antidepressive Agents; Antipsychotic Agents; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Agents; Histamine Antagonists; Humans; Hypoglycemic Agents; Steroids; Ursodeoxycholic Acid; Weight Gain

2005
[Various problems in therapy and prognosis of drug-induced liver diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Feb-10, Volume: 84, Issue:2

    Topics: Chemical and Drug Induced Liver Injury; Diet, Fat-Restricted; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Diseases; Phenobarbital; Prednisolone; Prognosis; Ursodeoxycholic Acid

1995

Other Studies

3 other study(ies) available for ursodeoxycholic acid and Adverse Drug Event

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab.
    Immunotherapy, 2019, Volume: 11, Issue:18

    Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bile Duct Diseases; Cholagogues and Choleretics; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunotherapy; Lung Neoplasms; Middle Aged; Nivolumab; Treatment Outcome; Ursodeoxycholic Acid

2019